251 related articles for article (PubMed ID: 31749286)
1. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
Borgatti A; Dickerson EB; Lawrence J
Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286
[TBL] [Abstract][Full Text] [Related]
2. Soft-tissue sarcomas in dogs: a review.
Ehrhart N
J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
[TBL] [Abstract][Full Text] [Related]
3. Surgery and electrochemotherapy of a high-grade soft tissue sarcoma in a dog.
Spugnini EP; Vincenzi B; Betti G; Cordahi F; Dotsinsky I; Mudrov N; Citro G; Baldi A
Vet Rec; 2008 Feb; 162(6):186-8. PubMed ID: 18263920
[No Abstract] [Full Text] [Related]
4. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy?
Atherton MJ; Lenz JA; Mason NJ
Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517
[TBL] [Abstract][Full Text] [Related]
5. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004).
Selting KA; Powers BE; Thompson LJ; Mittleman E; Tyler JW; Lafferty MH; Withrow SJ
J Am Vet Med Assoc; 2005 Nov; 227(9):1442-8. PubMed ID: 16279389
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
7. The potential of the combined use of targeted type I interferon pathway inhibitors and oncolytic viruses to treat sarcomas.
MacNeill AL
Vet Comp Oncol; 2020 Mar; 18(1):36-42. PubMed ID: 31618515
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin is a widely used chemotherapeutic agent with activity reported in many malignancies, including soft tissue sarcomas.
Greenberg MH; Friedland ML
Cancer Invest; 1989; 7(5):523. PubMed ID: 2620253
[No Abstract] [Full Text] [Related]
9. Soft tissue sarcomas in dogs.
Mayer MN; LaRue SM
Can Vet J; 2005 Nov; 46(11):1048, 1050, 1052. PubMed ID: 16363335
[No Abstract] [Full Text] [Related]
10. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic variables associated with primary abdominal visceral soft tissue sarcomas in dogs: A Veterinary Society of Surgical Oncology retrospective study.
Linden D; Liptak JM; Vinayak A; Grimes JA; Sandey M; Smiley W; Matz BM
Vet Comp Oncol; 2019 Sep; 17(3):265-270. PubMed ID: 30666781
[TBL] [Abstract][Full Text] [Related]
12. Radiation as a therapeutic modality in sarcomas of the soft tissue.
Suit H; Spiro I
Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
[TBL] [Abstract][Full Text] [Related]
13. Principles of treatment for soft-tissue sarcomas in the dog.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):118-22. PubMed ID: 12831074
[TBL] [Abstract][Full Text] [Related]
14. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
[TBL] [Abstract][Full Text] [Related]
15. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy.
Demetriou JL; Brearley MJ; Constantino-Casas F; Addington C; Dobson J
J Small Anim Pract; 2012 Mar; 53(3):174-81. PubMed ID: 22931399
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas.
de Queiroz GF; Dagli ML; Meira SA; Matera JM
Vet Comp Oncol; 2013 Sep; 11(3):230-5. PubMed ID: 22372675
[TBL] [Abstract][Full Text] [Related]
17. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
18. Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM; Ingham M; Spraker MB; Schwartz GK
J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291
[TBL] [Abstract][Full Text] [Related]
19. A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs.
Eward WC; Mito JK; Eward CA; Carter JE; Ferrer JM; Kirsch DG; Brigman BE
Clin Orthop Relat Res; 2013 Mar; 471(3):834-42. PubMed ID: 22972654
[TBL] [Abstract][Full Text] [Related]
20. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
